| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q9NW36 | Lymphoid-specific helicase; cDNA FLJ10339 fis, clone NT2RM2000740, weakly similar to POSSIBLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L; | HELLS; | NULL | 310 | human |
| E9PKR3 | Alkaline ceramidase 3; | ACER3; | NULL | 51 | human |
| H9N1E7 | Vascular endothelial growth factor receptor 1; p19FLT1; | FLT1; | NULL | 433 | human |
| E9LBL3 | Cytochrome b; | CYTB; | NULL | 380 | human |
| T2HUW8 | Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen-related cell adhesion molecule 5 isoform 3D; | CEACAM5; | NULL | 346 | human |
| B1AK88 | Capping protein (Actin filament) muscle Z-line, beta, isoform CRA_d; F-actin-capping protein subunit beta; | CAPZB; | NP_001269091.1; | 301 | human |
| B2RNX8 | Crm, cramped-like; Drosophila; | CRAMP1L; | NP_065876.3; | 1065 | human |
| Q75MH2 | IL6 protein; Putative uncharacterized protein IL6; Interleukin 6 (Interferon, beta 2), isoform CRA_a; Interleukin 6 (Interferon, beta 2); | IL6; | NP_000591.1; | 212 | human |
| Q96F92 | TAZ protein; Tafazzin; | TAZ; | NULL | 262 | human |
| Q85KS0 | Cytochrome c oxidase subunit 2; | COX2; COII coxII; | NULL | 227 | human |
| A1DT97 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| F1D8S3 | Nuclear receptor Rev-ErbA-alpha; Nuclear receptor subfamily 1, group D, member 1; | NR1D1; | NP_068370.1; | 614 | human |
| G3V153 | Caprin-1; GPI-anchored membrane protein 1, isoform CRA_d; | CAPRIN1; GPIAP1; | NULL | 628 | human |
| B3KSH1 | Eukaryotic translation initiation factor 3 subunit F; eIF3f; Eukaryotic translation initiation factor 3 subunit 5; eIF-3-epsilon; eIF3 p47; | EIF3F; EIF3S5; | NULL | 372 | human |
| Q6FII3 | C14orf1 protein; Chromosome 14 open reading frame 1, isoform CRA_a; cDNA, FLJ92025; | C14orf1; | NP_009107.1; | 140 | human |
| A5PKX9 | INADL protein; | INADL; | NULL | 1181 | human |
| A3QNQ0 | Transforming growth factor beta receptor II; cDNA, FLJ94789, highly similar to Homo sapiens transforming growth factor, beta receptor II(70/80kDa; TGFBR2), mRNA; Transforming growth factor, beta receptor II (70/80kDa), isoform CRA_a; Transforming growth f疏?疐 | TGFBR2; | NP_003233.4; | 567 | human |
| Q7Z7F4 | Prestin; | PRES; SLC26A5; | NULL | 746 | human |
| Q6FI00 | CCND1 protein (Cyclin D1, isoform CRA_c) (cDNA, FLJ93625, Homo sapiens cyclin D1; PRAD1: parathyroid adenomatosis 1; CCND1),mRNA; Cyclin D1 (PRAD1: parathyroid adenomatosis 1); | CCND1; | NP_444284.1; | 295 | human |
| A0A024R9W4 | Toll-like receptor; | TLR10; | NULL | 811 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |